Your browser doesn't support javascript.
loading
Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes.
Chu, Van Trung; Weber, Timm; Graf, Robin; Sommermann, Thomas; Petsch, Kerstin; Sack, Ulrike; Volchkov, Pavel; Rajewsky, Klaus; Kühn, Ralf.
Afiliación
  • Chu VT; Max-Delbrück-Center for Molecular Medicine, 13125, Berlin, Germany. VanTrung.Chu@mdc-berlin.de.
  • Weber T; Max-Delbrück-Center for Molecular Medicine, 13125, Berlin, Germany. Timm.Weber@mdc-berlin.de.
  • Graf R; Max-Delbrück-Center for Molecular Medicine, 13125, Berlin, Germany. Robin.graf@mdc-berlin.de.
  • Sommermann T; Max-Delbrück-Center for Molecular Medicine, 13125, Berlin, Germany. Thomas.sommermann@mdc-berlin.de.
  • Petsch K; Max-Delbrück-Center for Molecular Medicine, 13125, Berlin, Germany. Kerstin.Petsch@mdc-berlin.de.
  • Sack U; Present Address: Bayer Pharma AG Building S107, 13353, Berlin, Germany. ulrike.sack@bayer.com.
  • Volchkov P; Harvard University, Cambridge, MA, 02138, USA. vpwwww@gmail.com.
  • Rajewsky K; Max-Delbrück-Center for Molecular Medicine, 13125, Berlin, Germany. Klaus.Rajewsky@mdc-berlin.de.
  • Kühn R; Max-Delbrück-Center for Molecular Medicine, 13125, Berlin, Germany. ralf.kuehn@mdc-berlin.de.
BMC Biotechnol ; 16: 4, 2016 Jan 16.
Article en En | MEDLINE | ID: mdl-26772810
ABSTRACT

BACKGROUND:

The CRISPR/Cas9 system is increasingly used for gene inactivation in mouse zygotes, but homology-directed mutagenesis and use of inbred embryos are less established. In particular, Rosa26 knock-in alleles for the insertion of transgenes in a genomic 'safe harbor' site, have not been produced. Here we applied CRISPR/Cas9 for the knock-in of 8-11 kb inserts into Rosa26 of C57BL/6 zygotes.

RESULTS:

We found that 10-20 % of live pups derived from microinjected zygotes were founder mutants, without apparent off-target effects, and up to 50 % knock-in embryos were recovered upon coinjection of Cas9 mRNA and protein. Using this approach, we established a new mouse line for the Cre/loxP-dependent expression of Cas9.

CONCLUSIONS:

Altogether, our protocols and resources support the fast and direct generation of new Rosa26 knock-in alleles and of Cas9-mediated in vivo gene editing in the widely used C57BL/6 inbred strain.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ARN no Traducido / Técnicas de Sustitución del Gen / Sistemas CRISPR-Cas Límite: Animals Idioma: En Revista: BMC Biotechnol Asunto de la revista: BIOTECNOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ARN no Traducido / Técnicas de Sustitución del Gen / Sistemas CRISPR-Cas Límite: Animals Idioma: En Revista: BMC Biotechnol Asunto de la revista: BIOTECNOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Alemania